For a day when the major stock market indexes made 1% gains and volume rose from the previous day, the undercurrent was not very upbeat.
Not a single stock in the MarketSmith 250, an index of leading growth stocks maintained by IBD’s sister company, broke out of a base. There was a disappointing number of new highs all around.